Adaptive Arm Training for Children With Hemiplegia
Study Details
Study Description
Brief Summary
The goal of this research is to provide limb training in children with hemiplegia using a bimanual-to-unimanual training approach. Twenty pediatric patients aged 5-17 years with acquired brain injury will receive training on the bimanual-to-unimanual device for a period of 9 weeks. During the training, children use both arms to operate robotic arms to play a video game. We will assess changes in hand impairment after the training.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Bimanual Arm Training Children in the study will all receive the same treatment, which includes 9 weeks of training on the bimanual arm trainer robotic device. |
Device: Bimanual Arm Training
Device-based bimanual-to-unimanual training will be provided with the Bimanual Arm Trainer (BAT, Mirrored Motion Works, NC). The device provides bimanual-to-unimanual training of simultaneous shoulder external rotation and elbow extension, and independent training of pronation-supination and grasp and release of each hand. Range of motion and speed are recorded during training and feedback and motivation are provided through age-appropriate gaming modules.
|
Outcome Measures
Primary Outcome Measures
- Change in Assisting Hand Assessment [Before intervention compared to after intervention]
The Assisting Hand Assessment evaluated how effectively children use their hands to complete bimanual tasks.
- Change in Box and Box Test [Before intervention compared to after intervention]
The Box and Blocks test measures how many blocks a child can move with one hand from one box to another in one minute with the impaired hand.
- Change in range of motion [Before intervention compared to after intervention]
The robotic device measures range of motion of the shoulder.
Eligibility Criteria
Criteria
Inclusion Criteria:
- Hemiplegia due to brain injury at least 3 months before study enrollment.
Exclusion Criteria:
-
Any social or medical problem that precludes compliance with the protocol.
-
Treatment with botulinum toxin or intrathecal baclofen in the 3 months preceding enrollment.
-
Implanted neuromodulatory or electronic device or other complicating illness.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Kathleen M Friel | Hartsdale | New York | United States | 10530 |
Sponsors and Collaborators
- Blythedale Children's Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- BAT_Friel